Name (Synonyms) | Correlation | |
---|---|---|
D014777 | Virus Diseases NIH | 0.12 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
A 6-Week Prospective, Open label, Randomized, in Multicenter Study of, Oseltamivir 300mg per day plus Hydroxychloroquine 800 mg per day versus Combination of Lopipinavir 800mg (or 10 mg/kg ) per day and Ritonavir 200 mg ( or 2.5 mg/kg ) per day plus Oseltamivir 300 mg ( or 4-6 mg /kg ) per day versus Combination of Darunavir 400 mg every 8 hours plus ritonavir 200 mg (or 2.5 mg/kg ) per day plus Oseltamivir 300mg ( or 4-6 mg /kg ) per day plus Hydroxychloroquine 400 mg per day in mild COVID-19 and Combination of Lopipinavir 800 mg (or 10 mg/kg ) per day and Ritonavir 200 mg ( or 2.5 mg/kg ) per day plus Oseltamivir 300 mg ( or 4-6 mg /kg ) per day versus Favipiravir 2400 mg, 2400 mg, and 1200 mg every 8 h on day 1, and a maintenance dose of 1200 mg twice a day plus Lopipinavir 800 mg ( or 10 mg/kg ) per day and Ritonavir 200 mg ( or 2.5 mg/kg ) per day versus Combination of Darunavir 400 mg every 8 hours plus ritonavir 200 mg (or 2.5 mg/kg ) plus Oseltamivir 300 mg (or 4-6 mg /kg ) per day plus Hydroxychloroquine 400 mg per day versus Favipiravir 2400 mg, 2400 mg, and 1200 mg every 8 h on day 1, and a maintenance dose of 1200 mg twice a day plus Darunavir 400 mg every 8 hours Ritonavir 200 mg ( or 2.5 mg/kg ) per day plus Hydroxychloroquine 400 mg per day in moderate to critically illness in COVID-19
Description: Eradication of nasopharyngeal SARS-CoV-2
Measure: SARS-CoV-2 eradication time Time: Up to 24 weeksDescription: Any death after treatment adjusted by initial severity in each arm
Measure: Number of patient with Death Time: Up to 24 weeksDescription: Normal pulmonary function, normal O2 saturation after treatment Adjusted by initial severity in each arm
Measure: Number of patient with Recovery adjusted by initial severity in each arm Time: Up to 24 weeksDescription: Number of day with ventilator assistant
Measure: Number of day With ventilator dependent adjusted by initial severity in each arm Time: Up to 24 weeksDescription: Number of patient developed new ARDS
Measure: Number of patient developed Acute Respiratory Distress Syndrome After treatment Time: Up to 24 weeksDescription: Acute Respiratory Distress Syndrome Recovery rate
Measure: Number of patient with Acute Respiratory Distress Syndrome Recovery Time: Up to 24 weeks